Relay Therapeutics RLAY Insider Ownership

NASDAQ RLAY

$19.92 -0.47 (-2.31%)

As of: Nov 10, 2026 · 12:17 PM EST

Insider Holdings by Owner

24.62Mn Shares

Pauling (Cayman) Ltd Svf21.90Mn89.0%

Mark Murcko996.95K4.0%

Sanjiv Patel471.30K1.9%

Donald A Bergstrom396.88K1.6%

Brian Adams371.47K1.5%

Other insiders (5)478.98K1.9%

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

11.35%

▲+9.92% pp QoQ

Shares Held by Insiders

24.81Mn

filed for Sep 2026

▲+694.74% QoQ

Shares Outstanding

218.53Mn

218,531,200 shares

Direct Holdings

2.70Mn

Indirect: 22.10Mn

Net Open-Market Trades

-6.22Mn

net sold · -$120.75Mn in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Nov 5, 2026

In the last 12 months, insiders at Relay Therapeutics made open-market sales of $129.18 million (6.78Mn shares) and bought no shares on the open market.

Behind Relay Therapeutics' open-market sales in the past 12 months were 5 insiders, and no insider bought.
SVF Pauling (Cayman) Ltd (10% owner) was the top open-market seller of Relay Therapeutics over the past 12 months, with $116.4 million sold (6Mn shares) and the latest sale on August 25, 2026.
The latest open-market trade in RLAY stock by an insider was a sale of 2.25K shares for $41,932 by Donald A. Bergstrom (President, R&D) on October 28, 2026.
In transactions other than open-market trades, Relay Therapeutics insiders received 4.05K shares in stock awards and acquired 264.7K shares through option exercises and conversions over the past 12 months.
According to Business Quant data, insiders at Relay Therapeutics reported 24.73Mn shares in total in their latest Form 4 filings, or 11.32% of the 218.53Mn shares outstanding.
Direct holdings account for 2.63Mn shares (10.63%) of RLAY's insider total, and indirect holdings through trusts, partnerships and family members for 22.1Mn shares (89.37%).
Per Business Quant, 8 insiders of RLAY hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
Relay Therapeutics' three largest insider shareholders, based on their latest Form 4 filings, are SVF Pauling (Cayman) Ltd (10% owner, 21.9Mn shares), Mark Murcko (Director, 996.95K shares) and Sanjiv Patel (President and CEO, 670.85K shares).
Of the shares held by RLAY insiders, 88.56% belong to SVF Pauling (Cayman) Ltd.
In the last 12 months, 44 Form 4 filings with transactions in RLAY stock came from 12 insiders.
These insider figures for Relay Therapeutics are based on Form 4 filings through October 30, 2026.

Form 4 Holdings

Insiders Holding RLAY

Insiders 10

Shares held 24.62Mn

Of outstanding 11.27%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Pauling (Cayman) Ltd Svf	TenPercentOwner	0	21,904,963	21,904,963	89.0%	27 Aug, 2026
2	Mark Murcko	Director	996,952	0	996,952	4.0%	08 Sep, 2022
3	Sanjiv Patel	President And Ceo	471,301	0	471,301	1.9%	08 Oct, 2026
4	Donald A Bergstrom	President, Rd	396,878	0	396,878	1.6%	30 Oct, 2026
5	Brian Adams	Chief Legal Officer	371,472	0	371,472	1.5%	30 Jul, 2025
6	Peter Rahmer	Officer	222,904	0	222,904	0.9%	30 Oct, 2026
7	Thomas Catinazzo	Chief Financial Officer	103,665	0	103,665	0.4%	30 Oct, 2026
8	Jami Rubin	Director	67,242	0	67,242	0.3%	12 Jun, 2024
9	Andy Porter	Chief Administrative Officer	45,164	0	45,164	0.2%	01 Nov, 2022
10	Laura Shawver	Director	40,000	0	40,000	0.2%	26 May, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

533 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
28 Oct, 2026	Thomas Catinazzo	Chief Financial Officer	Disposed S	1,469	$18.62	$27.35K	103,665	Direct
28 Oct, 2026	Peter Rahmer	Officer	Disposed S	753	$18.62	$14.02K	222,904	Direct
28 Oct, 2026	Donald A Bergstrom	President, Rd	Disposed S	2,252	$18.62	$41.93K	396,878	Direct
07 Oct, 2026	Sanjiv Patel	President And Ceo	Disposed S	48,199	$18.10	$872.40K	471,301	Direct
06 Oct, 2026	Thomas Catinazzo	Chief Financial Officer	Disposed S	17,511	$18.58	$325.35K	105,340	Direct
06 Oct, 2026	Thomas Catinazzo	Chief Financial Officer	Disposed S	206	$19.26	$3.97K	105,134	Direct
08 Sep, 2026	Thomas Catinazzo	Chief Financial Officer	Disposed S	17,717	$18.94	$335.56K	122,851	Direct
08 Sep, 2026	Donald A Bergstrom	President, Rd	Disposed S	8,530	$18.97	$161.81K	399,130	Direct
08 Sep, 2026	Sanjiv Patel	President And Ceo	Disposed S	48,199	$18.94	$912.89K	519,500	Direct
26 Aug, 2026	Peter Rahmer	Officer	Disposed S	4,508	$20.03	$90.30K	223,657	Direct
25 Aug, 2026	Pauling (Cayman) Ltd Svf	TenPercentOwner	Disposed S	6,000,000	$19.40	$116.40Mn	21,904,963	Indirect
17 Aug, 2026	Sanjiv Patel	President And Ceo	Disposed S	48,199	$20.33	$979.89K	567,699	Direct
14 Aug, 2026	Thomas Catinazzo	Chief Financial Officer	Disposed S	17,717	$19.74	$349.73K	140,568	Direct
28 Jul, 2026	Thomas Catinazzo	Chief Financial Officer	Disposed S	1,459	$18.61	$27.15K	158,285	Direct
28 Jul, 2026	Donald A Bergstrom	President, Rd	Disposed S	2,237	$18.61	$41.63K	407,660	Direct
28 Jul, 2026	Peter Rahmer	Officer	Disposed S	748	$18.61	$13.92K	228,165	Direct
06 Jul, 2026	Donald A Bergstrom	President, Rd	Disposed S	8,660	$18.71	$162.03K	409,897	Direct
06 Jul, 2026	Thomas Catinazzo	Chief Financial Officer	Disposed S	17,717	$18.69	$331.13K	159,744	Direct
30 Jun, 2026	Sanjiv Patel	President And Ceo	Acquired A	3,056	$6.95	$21.24K	664,097	Direct
07 Jul, 2026	Sanjiv Patel	President And Ceo	Disposed S	48,199	$19.58	$943.74K	615,898	Direct

Showing 1 to 20 of 533 transactions